Cost-Effective Analysis Of Clozapine Compared With Olanzapine, Quetiapine, And Risperidone In The Management Of Patients With Treatment-Resistant Schizophrenia
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1390
https://www.valueinhealthjournal.com/article/S1098-3015(16)01458-3/fulltext
Title :
Cost-Effective Analysis Of Clozapine Compared With Olanzapine, Quetiapine, And Risperidone In The Management Of Patients With Treatment-Resistant Schizophrenia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01458-3&doi=10.1016/j.jval.2016.03.1390
First page :
A183
Section Title :
Mental Health - Clinical Outcomes Studies
Open access? :
No
Section Order :
516